Pa. Judge Explains Call To Keep $2.5M J&J Risperdal Verdict

Law360, Philadelphia (August 14, 2017, 4:09 PM EDT) -- A Pennsylvania state judge has explained his reason for denying a Johnson & Johnson unit’s request for a new trial over abnormal breast growth allegedly linked to the drug Risperdal, saying the company's “extraordinary” defense tactics warranted allowing an Alabama boy’s family to find a new expert witness during the case.

Judge Ramy Djerassi in the Philadelphia County Court of Common Pleas said Thursday that Janssen Pharmaceuticals Inc., which is currently appealing a $2.5 million verdict it was slapped with in the case, had waited until...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.